Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sight Sciences Inc (NQ: SGHT )

11.71 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.71
Bid (Size) 6.000 (7)
Ask (Size) 29.50 (1)
Prev. Close 11.71
Today's Range 11.71 - 11.71
52wk Range 5.350 - 21.89
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
From Sight Sciences, Inc.
Via Globe NewsWire
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga

Performance

YTD
-34.58%
-34.58%
1 Month
+47.85%
+47.85%
3 Month
+64.47%
+64.47%
6 Month
+22.88%
+22.88%
1 Year
-41.68%
-41.68%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
5 Analysts Have This to Say About Sight Sciences
Via Benzinga
Sight Sciences' Near-Term Upside Is Limited, Says This Analyst
Via Benzinga
4 Analysts Have This to Say About Sight Sciences
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Via Benzinga
Sight Sciences Posts Long-Term Safety, Effectiveness Data For Glaucoma Surgical System
Via Benzinga
Where Sight Sciences Stands With Analysts
Via Benzinga
Sight Sciences: Q2 Earnings Insights
Via Benzinga
Dow Turns Higher; Nasdaq Jumps Over 200 Points
Via Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Earnings Scheduled For August 11, 2022
Via Benzinga
Analyst Ratings for Sight Sciences
Via Benzinga
Nasdaq Surges 100 Points; Crude Oil Rises Sharply
Via Benzinga
US Stocks Mixed Following Thursday's Rally; Dow Drops 50 Points
Via Benzinga
Sight Sciences Reports Third Quarter 2022 Financial Results
From Sight Sciences, Inc.
Via Globe NewsWire
Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure
From Sight Sciences, Inc.
Via Globe NewsWire
Earnings Scheduled For November 10, 2022
Via Benzinga
Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022
From Sight Sciences, Inc.
Via Globe NewsWire
Morgan Stanley Maintains Overweight Rating for Sight Sciences: Here's What You Need To Know
Via Benzinga
Expert Ratings for Sight Sciences
Via Benzinga
Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED)
From Sight Sciences, Inc.
Via Globe NewsWire
Sight Sciences's Return On Capital Employed Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.